Chemung Financial Corporation
NASDAQ:CHMGBanks - Regional
+$0.15 today
- Market cap
- $398.12M
- Beta
- 0.62
- P/E (TTM)
- 18.6
- EPS (TTM)
- $3.79
- Dividend yield
- 1.93%
Volume 0.03M
Average 0.03M
CHMG EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Chemung Financial CorporationNASDAQ: CHMG
EBITDA · Q1 FY2026 · quarter ended Mar 2026
EBITDA growth accelerates
Q1 FY2026 EBITDA of $12.54M rose 50.2% year over year, ahead of the -14.3% change in trailing-twelve-month EBITDA. Sequentially, it rose 6.7% from the prior quarter. Over 3 fiscal years it compounded at -17.3% a year.
Context
- EBITDA amounted to 16.2% of revenue in FY2025, down 5.3 pp from a year earlier.
- EBITDA increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 3 analysts of $55.11M (+143.8%) for the fiscal year ending Dec 2026, a step up from the -29.6% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $12.54M+6.7% QoQ
- Last fiscal yearDec 2025
- $22.6M-29.6% YoY
- LTMMar 2026
- $26.79M-14.3% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +50.2% | +244.5% | +194.4 pp |
| 1 year | -29.6% | +143.8% | +173.4 pp |
| 3-year CAGR | -17.3% | +37.4% | +54.6 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 22.6M USD
- Year-over-year change
- -29.6%
- 4-year CAGR
- -11.7%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 22.6M | -29.6% |
| FY2024 | 2024-12-31 | 32.1M | -6.4% |
| FY2023 | 2023-12-31 | 34.3M | -14.1% |
| FY2022 | 2022-12-31 | 39.92M | +7.1% |
| FY2021 | 2021-12-31 | 37.26M | — |
EBITDA vs competitors
How CHMG compares with its peers on the latest reported figures
- CHMG's LTM Mar 2026 EBITDA of $26.79M is the 10th highest of the 11 companies compared; the peer median is $31.87M.
- Its year-over-year change of -14.3% is the lowest of 11, against a peer median of +32.4%.
- EBITDA amounts to 18.8% of revenue for CHMG, versus a peer median of 25.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $49.13M | +35.3% | +7.3% | 28.1% | |
| LTM Mar 2026 | $40.03M | +29.6% | -1.7% | 28.1% | |
| LTM Mar 2026 | $38.6M | +26.3% | -4.0% | 20.4% | |
| LTM Mar 2026 | $34.36M | +1138.3% | -1.2% | 25.5% | |
| LTM Mar 2026 | $31.89M | +96.4% | +14.5% | 23.7% | |
| LTM Mar 2026 | $31.86M | -3.0% | +1.0% | 35.5% | |
| LTM Mar 2026 | $30.42M | +23.9% | -3.4% | 24.8% | |
| LTM Mar 2026 | $30.3M | +39.3% | -0.7% | 14.7% | |
CBNAChain Bridge Bancorp, Inc. | LTM Mar 2026 | $27.75M | -4.0% | +34.2% | 44.8% |
| LTM Mar 2026 | $26.79M | -14.3% | -17.3% | 18.8% | |
| LTM Mar 2026 | $24.94M | +49.1% | -17.2% | 18.8% | |
| Peer median (excluding CHMG) | $31.87M | +32.4% | -1.0% | 25.1% | |
Competitors are the stored peer set for CHMG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 91.84M | 101.91M | 136.58M | 149.61M | 139.94M |
| Cost of Revenue | 3.44M | 6.74M | 41.88M | 53.46M | 50.12M |
| Gross Profit | 88.41M | 95.17M | 94.7M | 96.15M | 89.83M |
| Gross Margin | 96.3% | 93.4% | 69.3% | 64.3% | 64.2% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 32.7M | 33.37M | 36.58M | 38.93M | 41.82M |
| Operating Expenses | 54.65M | 58.28M | 63.2M | 66.07M | 69.89M |
| Depreciation & Amortization | 3.5M | 3.03M | 2.8M | 2.02M | 2.67M |
| EBITDA | 37.26M | 39.92M | 34.3M | 32.1M | 22.6M |
| EBITDA Margin | 40.6% | 39.2% | 25.1% | 21.5% | 16.2% |
| Operating Income | 33.76M | 36.89M | 31.5M | 30.09M | 19.94M |
| Operating Margin | 36.8% | 36.2% | 23.1% | 20.1% | 14.2% |
| Interest Income | 69.01M | 81.48M | 113.07M | 127.56M | 132.84M |
| Interest Expense | 3.42M | 7.3M | 38.62M | 53.51M | 45.68M |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 33.76M | 36.89M | 31.5M | 30.09M | 19.94M |
| Pre-Tax Margin | 36.8% | 36.2% | 23.1% | 20.1% | 14.2% |
| Income Tax Expense | 7.34M | 8.11M | 6.5M | 6.41M | 4.83M |
| Net Income | 26.43M | 28.78M | 25M | 23.67M | 15.1M |
| Net Margin | 28.8% | 28.2% | 18.3% | 15.8% | 10.8% |
| EPS (Basic) | 5.64 | 6.13 | 5.28 | 4.96 | 3.13 |
| EPS (Diluted) | 5.64 | 6.13 | 5.28 | 4.96 | 3.13 |
| Weighted Avg Shares | 4.68M | 4.69M | 4.73M | 4.77M | 4.81M |
| Weighted Avg Shares (Diluted) | 4.68M | 4.69M | 4.73M | 4.77M | 4.81M |
Chemung Financial Corporation
NASDAQ:CHMG
Intrinsic Alpha fair value
Locked
Current Price
$82.55
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.